Kirsten M. Scott
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Long QT syndrome causing an apparently typical first seizure.
Journal: Practical neurology
Published: November 03, 2025
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.
Journal: The Lancet. Neurology
Published: July 09, 2025
Phase 1, randomized trials of MEDI1341: cerebrospinal fluid free α-synuclein lowered by >50.
Journal: Brain communications
Published: December 03, 2024
The profile of gastrointestinal dysfunction in prodromal to late-stage Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: September 05, 2024
Validation of a 5-Year Prognostic Model for Parkinson's Disease.
Journal: Movement disorders clinical practice
Published: July 08, 2024
B Lymphocytes in Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: August 08, 2022
B lymphocyte responses in Parkinson's disease and their possible significance in disease progression.
Journal: Brain communications
Published: February 08, 2022
T lymphocyte senescence is attenuated in Parkinson's disease.
Journal: Journal of neuroinflammation
Published: July 08, 2021
Deciphering neurological symptoms in ANCA-associated vasculitis, uncontrolled disease or a complication of therapy.
Journal: Rheumatology (Oxford, England)
Published: December 08, 2020
Differences in the Presentation and Progression of Parkinson's Disease by Sex.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: May 22, 2020
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease.
Journal: Brain, behavior, and immunity
Published: October 01, 2019
Gut-educated IgA plasma cells defend the meningeal venous sinuses.
Journal: Nature
Published: September 26, 2019
Last Updated: 09/26/2026